ASSESSMENT OF THE EFFECTIVENESS OF THE USE OF FLUCONAZOLE AS ANTIFUNGAL PROPHYLAXIS IN THE ALLOGENEIC TRANSPLANT OF HEMATOPOIETIC PROGENITORS

被引：0
|
作者：
Revilla Calvo, N. [1 ]
Garcia-Gutierrez, V [1 ]
Herrera, P. [1 ]
Calbacho, M. [1 ]
Chinea, A. [1 ]
Jimenez, A. [1 ]
Fonseca, J. [1 ]
Saavedra, I [1 ]
Lopez-Jimenez, J. [1 ]
机构：
[1] Hosp Univ Ramon & Cajal, Serv Hematol & Hemoterapia, Madrid, Spain
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PB-150
引用
收藏
页码：295 / 296
页数：2
相关论文
共 50 条
  • [31] Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients - A multicenter, randomized trial
    Winston, DJ
    Maziarz, RT
    Chandrasekar, PH
    Lazarus, HM
    Goldman, M
    Blumer, JL
    Leitz, GJ
    Territo, MC
    ANNALS OF INTERNAL MEDICINE, 2003, 138 (09) : 705 - 713
  • [32] Antifungal prophylaxis with voriconazole in allogeneic hematopoietic stem cell transplantation recipients
    Magalhaes-Silverman, M
    Carter, T
    Hohl, R
    Shamsuddin, H
    Gingrich, R
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 89 - 89
  • [33] Effectiveness of letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplant recipients: A global systematic review
    Sepassi, Aryana
    Saunders, Ila M.
    Bounthavong, Mark
    Taplitz, Randy A.
    Logan, Cathy
    Watanabe, Jonathan H.
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (04) : 1138 - 1149
  • [34] Fluconazole-Induced adrenal insufficiency following allogeneic hematopoietic cell transplant
    Freyer, Craig W.
    Loren, Alison W.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (08) : 1922 - 1925
  • [35] Antifungal Agents for Secondary Prophylaxis Based on Response to Initial Antifungal Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Prior Pulmonary Aspergillosis
    Liu, Qifa
    Lin, Ren
    Sun, Jing
    Xiao, Yang
    Nie, Danian
    Zhang, Yu
    Huang, Fen
    Fan, Zhiping
    Zhou, Hongsheng
    Jiang, Qianli
    Zhang, Fuhua
    Zhai, Xiao
    Xu, Dan
    Wei, Yongqiang
    Song, Jiayin
    Li, Yiqing
    Feng, Ru
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1198 - 1203
  • [36] THE MSKCC EXPERIENCE WITH OUTPATIENT INTERMITTENT DOSING OF MICAFUNGIN FOR ANTIFUNGAL PROPHYLAXIS AND TREATMENT FOLLOWING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT
    Goldberg, J. D.
    Barker, J. N.
    Castro-Malaspina, H. R.
    Jakubowski, A. A.
    Abboud, M.
    Tucker, A.
    Ford, R.
    Perales, M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S263 - S263
  • [37] Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
    N S Hamza
    M A Ghannoum
    H M Lazarus
    Bone Marrow Transplantation, 2004, 34 : 377 - 389
  • [38] Choices aplenty: antifungal prophylaxis in hematopoietic stem cell transplant recipients
    Hamza, NS
    Ghannoum, MA
    Lazarus, HM
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 377 - 389
  • [39] EFFECTIVENESS OF LETERMOVIR FOR CYTOMEGALOVIRUS PROPHYLAXIS IN SEROPOSITIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: A GLOBAL SYSTEMATIC REVIEW
    Sepassi, A.
    Saunders, I
    Bounthavong, M.
    Watanabe, J.
    VALUE IN HEALTH, 2022, 25 (07) : S322 - S322
  • [40] Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis
    E Jantunen
    A Nihtinen
    L Volin
    E Juvonen
    T Parkkali
    T Ruutu
    V-J Anttila
    Bone Marrow Transplantation, 2004, 34 : 891 - 895
12345